跳至主要内容
临床试验/TCTR20210809008
TCTR20210809008已完成1 期

ASSESSMENT OF DRUG-THERAPY AND HEALTH-RELATED QUALITY OF LIFE IN CANCER PATIENTS RECEIVING PHARMACEUTICAL CARE VERSUS USUAL CARE

/A0 个研究点目标入组 237 人开始时间: 2021年8月9日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
237

研究概览

简要总结

Pharmaceutical care provision increased drug-therapy and health-related quality of life among cancer patients receiving chemotherapy more than usual care did. Achieving desired outcomes require both patient-centered care and a sensitive instrument.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • Patients receiving treatment at the chemotherapy unit, Samutprakarn Hospital from November 2020 to Fabruary 2021.
  • Patients receiving chemotherapy drugs at every cycle except the last cycle.
  • 18 years old or older.
  • Not disabled. No psychoactive symptoms. O Patients agree to participate in the study.

排除标准

  • Patients referred to other hospitals
  • Patients loss follow-up
  • Patients death

研究者

发起方
/A

相似试验